CONMED Corporation (CNMD)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 962,681 | 932,896 | 881,832 | 854,664 | 834,222 | 796,205 | 780,194 | 752,453 | 745,545 | 716,337 | 672,968 | 789,546 | 785,435 | 755,683 | 744,499 | 725,570 | 709,038 | 683,141 | 674,898 | 701,635 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $962,681K
= 0.00
CONMED Corporation's debt-to-equity ratio has consistently been reported as 0.00 since March 31, 2020, until December 31, 2024. This indicates that the company has not utilized any debt to finance its operations and growth during this period. A debt-to-equity ratio of 0.00 typically signifies that the company is primarily relying on equity financing rather than debt financing. This could suggest that CONMED Corporation has a strong financial position with a lower level of financial risk associated with debt obligations.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-equity ratio
CONMED Corporation
CNMD
0.00
BioLife Solutions Inc
BLFS
0.01
LivaNova PLC
LIVN
0.42
Masimo Corporation
MASI
0.69
Medtronic PLC
MDT
0.00
TransMedics Group Inc
TMDX
0.00